Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Contraception and Contraceptive Drugs

Free Subscription Articles published in Obstet Gynecol Retrieve available abstracts of 51 articles: HTML format

Single Articles

November 2025
1. 
   ACOG Committee Statement No. 21: Access to Contraception.
   Obstet Gynecol. 2025;146:e88-e97.
   PubMed     Abstract available
   
   
   August 2025
2. PEARSON A, Shvartsman K, Zeng W, Brown J, et al
   Cost Effectiveness of Salpingectomy Compared With Vasectomy for Permanent Contraception.
   Obstet Gynecol. 2025 Aug 28. doi: 10.1097/AOG.0000000000006042.
   PubMed     Abstract available
   
   
   
3. KUMASAKA JK, Mandelbaum AD, Edelman AB, Caughey AB, et al
   Cost Effectiveness of Over-the-Counter Availability of Progestin-Only Contraceptive Pills in Abortion-Restrictive and Abortion-Protective Settings.
   Obstet Gynecol. 2025 Aug 21. doi: 10.1097/AOG.0000000000006048.
   PubMed     Abstract available
   
   
   June 2025
4. ARORA KS, Larkin S, Milne J, Carmona Clavijo G, et al
   Goals and Priorities of Community Members Regarding the Federally Mandated Medicaid Sterilization Policy.
   Obstet Gynecol. 2025;146:394-401.
   PubMed     Abstract available
   
   
   May 2025
5. SMEREKA MI, Vivas-Valencia C, Testa A, Byrne JJ, et al
   Expanding Access to Quality Reproductive Health Care After the Dobbs v. Jackson Women's Health Organization Decision.
   Obstet Gynecol. 2025;146:195-201.
   PubMed     Abstract available
   
   
   
6. KOU L, Huang C, Xiao D, Liao S, et al
   Pharmacologic Interventions for Endometriosis-Related Pain: A Systematic Review and Meta-analysis.
   Obstet Gynecol. 2025 May 15. doi: 10.1097/AOG.0000000000005923.
   PubMed     Abstract available
   
   
   March 2025
7. YUK JS, Kim MH, Yoon SH, Han GH, et al
   Association Between Levonorgestrel-Releasing Intrauterine System Exposure Duration and Breast Cancer Incidence.
   Obstet Gynecol. 2025 Mar 13. doi: 10.1097/AOG.0000000000005881.
   PubMed     Abstract available
   
   
   February 2025
8. CARMODY MD, Schultz AL, Berg KA, Bullington BW, et al
   Association Between Comorbidities and Inpatient Postpartum Permanent Contraception Completion.
   Obstet Gynecol. 2025 Feb 6. doi: 10.1097/AOG.0000000000005844.
   PubMed     Abstract available
   
   
   
9. SOLOMON MD, Zaritsky EF, Warton M, Millman A, et al
   Effects of the Affordable Care Act on Contraception, Pregnancy, and Pregnancy Termination Rates.
   Obstet Gynecol. 2025;145:196-203.
   PubMed     Abstract available
   
   
   January 2025
10. STEENLAND MW, Oviedo D, Bates MA, Zhou A, et al
    Effect of an Intensive Nurse Home Visiting Program on Postpartum Contraceptive Use and Birth Spacing: A Randomized Controlled Trial.
    Obstet Gynecol. 2025;145:3-12.
    PubMed     Abstract available
    
    
    December 2024
11. FRIEDMAN M, Mor L, Shazar R, Paul N, et al
    Treatment of Early Pregnancy Loss With Mifepristone and Misoprostol Compared With Misoprostol Only.
    Obstet Gynecol. 2024 Dec 5. doi: 10.1097/AOG.0000000000005800.
    PubMed     Abstract available
    
    
    
12. 
    ACOG Committee Statement No. 13: Self-Managed Abortion.
    Obstet Gynecol. 2024;144:e152-e159.
    PubMed     Abstract available
    
    
    November 2024
13. SOLOMON MD, Zaritsky EF, Warton M, Millman A, et al
    Effects of the Affordable Care Act on Contraception, Pregnancy, and Pregnancy Termination Rates.
    Obstet Gynecol. 2024 Nov 1. doi: 10.1097/AOG.0000000000005796.
    PubMed     Abstract available
    
    
    September 2024
14. CASTANO PM
    Postpartum Long-Acting Reversible Contraception: Cost Effectiveness and Patient Desires in a Larger Context.
    Obstet Gynecol. 2024;144:291-293.
    PubMed    
    
    
    August 2024
15. WERNICK HJ, Abdel-Rasoul M, Berlan ED, Bonny AE, et al
    Body Mass Index Changes Among Adolescents and Young Adults Using the Etonogestrel Contraceptive Implant.
    Obstet Gynecol. 2024 Aug 30. doi: 10.1097/AOG.0000000000005712.
    PubMed     Abstract available
    
    
    
16. 
    Rates of Female Sterilization, Vasectomy, and LARC Placement Before and After the Dobbs Decision: A Retrospective Cohort Study [ID 2683404].
    Obstet Gynecol. 2024;144:e46.
    PubMed    
    
    
    July 2024
17. BULLARD KA, Ramanadhan S, Caughey AB, Rodriguez MI, et al
    Immediate Postpartum Long-Acting Reversible Contraception for Preventing Severe Maternal Morbidity: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2024 Jul 25. doi: 10.1097/AOG.0000000000005679.
    PubMed     Abstract available
    
    
    
18. SIMMONS RG, Carter G, Sanders JN, Turok DK, et al
    Assessing Contraceptive Switching and Discontinuation Over 3 Years in the HER Salt Lake Study.
    Obstet Gynecol. 2024;144:79-88.
    PubMed     Abstract available
    
    
    May 2024
19. SIMMONS RG, Carter G, Sanders JN, Turok DK, et al
    Assessing Contraceptive Switching and Discontinuation Over 3 Years in the HER Salt Lake Study.
    Obstet Gynecol. 2024 May 23. doi: 10.1097/AOG.0000000000005621.
    PubMed     Abstract available
    
    
    
20. MEYER R, Toussia-Cohen S, Shats M, Segal O, et al
    24-Hour Compared With 12-Hour Mifepristone-Misoprostol Interval for Second-Trimester Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2024 May 23. doi: 10.1097/AOG.0000000000005535.
    PubMed     Abstract available
    
    
    April 2024
21. MURPHY E, Pelletier A, Fay K, Bartz D, et al
    National Postpartum Permanent Contraception Practices and Perceived Barriers.
    Obstet Gynecol. 2024 Apr 16. doi: 10.1097/AOG.0000000000005584.
    PubMed     Abstract available
    
    
    February 2024
22. 
    Permanent Contraception: Ethical Issues and Considerations: ACOG Committee Statement No. 8.
    Obstet Gynecol. 2024;143:e31-e39.
    PubMed     Abstract available
    
    
    January 2024
23. BAUERFEIND A, von Stockum S, Boehnke T, Heinemann K, et al
    Venous Thromboembolic Risk of Estradiol Valerate-Dienogest Compared with Ethinyl Estradiol-Levonorgestrel Combined Oral Contraceptives.
    Obstet Gynecol. 2024 Jan 16. doi: 10.1097/AOG.0000000000005509.
    PubMed     Abstract available
    
    
    
24. KRASHIN JW, Black P, Brannen E, Gard CC, et al
    Geographic Access to Early Pregnancy Loss Management.
    Obstet Gynecol. 2024 Jan 11. doi: 10.1097/AOG.0000000000005505.
    PubMed     Abstract available
    
    
    
25. 
    ACOG Clinical Consensus No. 3: General Approaches to Medical Management of Menstrual Suppression: Correction.
    Obstet Gynecol. 2024;143:e20.
    PubMed    
    
    
    December 2023
26. IZATT A, Greenberg RA, Thorne J, Erdman J, et al
    Ethical and Legal Considerations for Sterilization Refusal in Nulliparous Women.
    Obstet Gynecol. 2023;142:1316-1321.
    PubMed     Abstract available
    
    
    
27. MITCHELL L, Vellanki B, Tang L, Hunter K, et al
    Contraceptive Provision to Women With Intellectual and Developmental Disabilities Enrolled in Medicaid.
    Obstet Gynecol. 2023;142:1477-1485.
    PubMed     Abstract available
    
    
    
28. MITCHELL L, Vellanki B, Tang L, Hunter K, et al
    Contraceptive Provision to Women With Intellectual and Developmental Disabilities Enrolled in Medicaid.
    Obstet Gynecol. 2023;142:1477-1485.
    PubMed     Abstract available
    
    
    November 2023
29. RAMANADHAN S, Jensen J
    The Levonorgestrel-Releasing Intrauterine Device as Emergency Contraception: Re-examining the Data.
    Obstet Gynecol. 2023 Nov 21. doi: 10.1097/AOG.0000000000005466.
    PubMed     Abstract available
    
    
    
30. ALLEN RH, Bartz D
    Opill: The Over-the-Counter Contraceptive Pill.
    Obstet Gynecol. 2023 Nov 9. doi: 10.1097/AOG.0000000000005455.
    PubMed     Abstract available
    
    
    
31. EBERLE A, Nguyen DB, Smith JP, Mansour FW, et al
    Medical Management of Ovarian Endometriomas: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023 Nov 9. doi: 10.1097/AOG.0000000000005444.
    PubMed     Abstract available
    
    
    October 2023
32. MITCHELL L, Vellanki B, Tang L, Hunter K, et al
    Contraceptive Provision to Women With Intellectual and Developmental Disabilities Enrolled in Medicaid.
    Obstet Gynecol. 2023 Oct 26. doi: 10.1097/AOG.0000000000005421.
    PubMed     Abstract available
    
    
    
33. HENKEL A, Miller HE, Zhang J, Lyell DJ, et al
    Prior Cesarean Birth and Risk of Uterine Rupture in Second-Trimester Medication Abortions Using Mifepristone and Misoprostol: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023 Oct 26. doi: 10.1097/AOG.0000000000005259.
    PubMed     Abstract available
    
    
    
34. 
    Association of the Cervicovaginal Microbiome With Contraceptive Methods in Hispanic Women Living in Puerto Rico [ID: 1376364]: Correction.
    Obstet Gynecol. 2023;142:996.
    PubMed    
    
    
    September 2023
35. BULLINGTON BW, Berg KA, Miller ES, Boozer M, et al
    Association Among Race, Ethnicity, Insurance Type, and Postpartum Permanent Contraception Fulfillment.
    Obstet Gynecol. 2023 Sep 7. doi: 10.1097/AOG.0000000000005328.
    PubMed     Abstract available
    
    
    August 2023
36. DARNEY BG, Biel FM, Oakley J, Coleman-Minahan K, et al
    Contraceptive Method Switching and Long-Acting Reversible Contraception Removal in U.S. Safety Net Clinics, 2016-2021.
    Obstet Gynecol. 2023 Aug 3. doi: 10.1097/AOG.0000000000005277.
    PubMed     Abstract available
    
    
    
37. FASSETT MJ, Reed SD, Rothman KJ, Pisa F, et al
    Risks of Uterine Perforation and Expulsion Associated With Intrauterine Devices.
    Obstet Gynecol. 2023 Aug 3. doi: 10.1097/AOG.0000000000005299.
    PubMed     Abstract available
    
    
    July 2023
38. MOSESON H, Jayaweera R, Egwuatu I, Grosso B, et al
    Effectiveness of Self-Managed Medication Abortion Between 9 and 16 Weeks of Gestation.
    Obstet Gynecol. 2023 Jul 6. doi: 10.1097/AOG.0000000000005266.
    PubMed     Abstract available
    
    
    
39. 
    Medicaid and Fulfillment of Postpartum Permanent Contraception Requests: Correction.
    Obstet Gynecol. 2023;142:221-222.
    PubMed    
    
    
    
40. 
    Increasing Access to Intrauterine Devices and Contraceptive Implants: ACOG Committee Statement No. 5: Correction.
    Obstet Gynecol. 2023;142:221.
    PubMed    
    
    
    May 2023
41. VALERIE F
    Where Do We Stand With Mifepristone in the United States?: Making Sense of the Madness.
    Obstet Gynecol. 2023 May 24. doi: 10.1097/AOG.0000000000005253.
    PubMed    
    
    
    
42. QURESHEY EJ, Ibarra CJ, Wagner SM, Chen HY, et al
    Effect of a Multimedia Educational Tool on Contraception Use 1 Year Postpartum.
    Obstet Gynecol. 2023 May 4. doi: 10.1097/AOG.0000000000005198.
    PubMed     Abstract available
    
    
    
43. ARORA KS, Chua A, Miller E, Boozer M, et al
    Medicaid and Fulfillment of Postpartum Permanent Contraception Requests.
    Obstet Gynecol. 2023;141:918-925.
    PubMed     Abstract available
    
    
    
44. NEBLETT MF 2ND, Stewart EA
    Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas.
    Obstet Gynecol. 2023;141:901-910.
    PubMed     Abstract available
    
    
    April 2023
45. PEARLMAN SHAPIRO M, Myo M, Chen T, Nathan A, et al
    Remote Provision of Medication Abortion and Contraception Through Telemedicine.
    Obstet Gynecol. 2023 Apr 13. doi: 10.1097/AOG.0000000000005205.
    PubMed     Abstract available
    
    
    
46. CREININ MD, Jensen JT, Chen MJ, Black A, et al
    Combined Oral Contraceptive Adherence and Pregnancy Rates.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005155.
    PubMed     Abstract available
    
    
    
47. CREININ MD, Barnhart KT, Gawron LM, Eisenberg D, et al
    Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005137.
    PubMed     Abstract available
    
    
    
48. CHEN BA, Kimble T, Harris LH, Kerns JL, et al
    Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005147.
    PubMed     Abstract available
    
    
    
49. SUZUKI Y, Chen L, Hou JY, St Clair CM, et al
    Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005124.
    PubMed     Abstract available
    
    
    
50. 
    Increasing Access to Intrauterine Devices and Contraceptive Implants: ACOG Committee Statement No. 5.
    Obstet Gynecol. 2023;141:866-872.
    PubMed     Abstract available
    
    
    March 2023
51. SCHWARTZ BI, Bear B, Short VL, Kazak AE, et al
    Outcomes of Menstrual Management Use in Transgender and Gender-Diverse Adolescents.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005123.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge.